W135 Meningococcal Disease in Africa

W135 Meningococcal Disease in Africa

Bibliografski detalji
Glavni autori:	Pollard, A, Santamaria, M, Maiden, M, Nicolas, P, Handford, S, Issa, M, Longworth, E, Jacobsson, S, Parent du Chatelet, I, Koumare, B, Soriano-Gabarro, M, Achtman, M, Greenwood, B, LaForce, M
Format:	Journal article
Jezik:	English
Izdano:	2003

Slični predmeti

Epidemic meningococcal disease in sub-Saharan Africa--towards a sustainable solution?
od: Pollard, A, i dr.
Izdano: (2003)

Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.
od: Pace, D, i dr.
Izdano: (2007)

Structural variation and immune recognition of the P1.2 subtype meningococcal antigen.
od: Tzitzilonis, C, i dr.
Izdano: (2006)

Serogroup W135 Meningococcal Disease, The Gambia, 2012
od: M. Jahangir Hossain, i dr.
Izdano: (2013-09-01)

Editorial commentary: The endgame for serogroup A meningococcal disease in Africa?
od: Maiden, M
Izdano: (2013)

Meningococcal W135 Disease Vaccination Intent, the Netherlands, 2018–2019
od: Liesbeth Claassen Marion de Vries, i dr.
Izdano: (2020-07-01)

Developmental strategy for a new Group A meningococcal conjugate vaccine (MenAfriVacR)
od: Prasad S. Kulkarni, i dr.
Izdano: (2018-05-01)

Serogroup W135 Meningococcal Meningitis, Northern Cameroon, 2007–2008
od: Denis Massenet, i dr.
Izdano: (2009-02-01)

Serogroup W-135 Meningococcal Disease during the Hajj, 2000
od: Jairam R. Lingappa, i dr.
Izdano: (2003-06-01)

MEMORY B CELL RESPONSES FOLLOWING IMMUNISATION WITH POLYSACCHARIDE AND CONJUGATE QUADRIVALENT MENINGOCOCCAL ACYW135 VACCINES IN HEALTHY ADULT VOLUNTEERS
od: Maheshi, R, i dr.
Izdano: (2010)

The Course of Generalized Meningococcal Infection Caused by Meningococcus Serogroup W135
od: M. V. Ivanova, i dr.
Izdano: (2016-11-01)

Evolutionary and genomic insights into meningococcal biology
od: Bratcher, H, i dr.
Izdano: (2012)

Metabolic shift in the emergence of hyperinvasive pandemic meningococcal lineages
od: Watkins, E, i dr.
Izdano: (2017)

Recent progress in the prevention of serogroup B meningococcal disease
od: Feavers, I, i dr.
Izdano: (2017)

Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps
od: F. Marc LaForce, i dr.
Izdano: (2018-05-01)

Meningitis and meningococcal septicaemia.
od: Pollard, A, i dr.
Izdano: (1998)

Vaccines for prevention of meningococcal disease.
od: Pollard, A, i dr.
Izdano: (2000)

Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135.
od: Keyserling, H, i dr.
Izdano: (2006)

Control of invasive meningococcal disease: is it achievable?
od: Marshall, H, i dr.
Izdano: (2016)

Meningococcal antigen in diagnosis and treatment of group A meningococcal infections.
od: Whittle, H, i dr.
Izdano: (1975)

Meningococcal disease
od: Pollard, A
Izdano: (2018)

Secondary cases of meningococcal disease.
od: Pollard, A, i dr.
Izdano: (1996)

Haplotypic diversity in human CEACAM genes: effects on susceptibility to meningococcal disease.
od: Callaghan, M, i dr.
Izdano: (2008)

Haplotypic diversity in human CEACAM genes: effects on susceptibility to meningococcal disease
od: Callaghan, M, i dr.
Izdano: (2008)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
od: Samba O. Sow, i dr.
Izdano: (2023-08-01)

Serogroup B meningococcal vaccines-an unfinished story.
od: Sadarangani, M, i dr.
Izdano: (2010)

Variation in the Neisseria lactamica porin, and its relationship to meningococcal PorB.
od: Bennett, J, i dr.
Izdano: (2008)

Outbreak of Serogroup W135 Meningococcal Disease after the Hajj Pilgrimage, Europe, 2000
od: Jean-François Aguilera, i dr.
Izdano: (2002-08-01)

Meningitis and meningococcal septicaemia - Extended review
od: Pollard, A, i dr.
Izdano: (1998)

Meningococcal vaccines.
od: Rüggeberg, J, i dr.
Izdano: (2004)

Meningococcal vaccines.
od: Collins, C, i dr.
Izdano: (2002)

Meningococcal vaccines.
od: Bethell, D, i dr.
Izdano: (2002)

Persistence of hyperinvasive meningococcal strain types during global spread as recorded in the PubMLST database
od: Watkins, E, i dr.
Izdano: (2012)

The effect of immune selection on the structure of the meningococcal opa protein repertoire.
od: Callaghan, M, i dr.
Izdano: (2008)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
od: Read, R, i dr.
Izdano: (2014)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial
od: Read, R, i dr.
Izdano: (2014)

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
od: Hedari CP, i dr.
Izdano: (2014-04-01)

The impact of nucleotide sequence analysis on meningococcal vaccine development and assessment
od: Maiden, MCJ
Izdano: (2019)

Emergency management of meningococcal disease.
od: Pollard, A, i dr.
Izdano: (1999)

Can we control all-cause meningococcal disease in Europe?
od: Sadarangani, M, i dr.
Izdano: (2016)